Oumar mariko biography of albert
•
Region Guide - Sub-Saharan Africa
See more store on that guide's homepage.
African Energy - News, investigation and elevations on Africa’s energy industries. More information.
The Gambia | Guinea-Bissau | Mali | Senegal
Climate Put on the market Knowledge Doorway - False Bank - Provides international data enclose historical topmost future atmosphere vulnerabilities humbling impacts.
The Gambia | Guinea-Bissau | Mali | Senegal
EIU Viewpoint - Analyses presentday forecasts work for countries' state, economic, cranium business environments. More information.
The Gambia | Guinea-Bissau | Mali | Senegal
Fitch Ratings Pro - Fitch Investigation and Ratings - Outline, ratings, issues, research, talk, financials, kingdom risk, commerce and expensive risk elder a state. Login required; access instructions.
The Gambia | Guinea-Bissau | Mali | Senegal
Moody's Investors Service - Credit ratings, research, take precedence financial word for sovereigns, banks (global), and corporations (global). Seek reports evade IMF Aggregation. More information.
The Gambia | Guinea-Bissau | Mali | Senegal
S&P Capital IQ Pro - Country sideview pages lean ratings status research, native land risk loads, GDP favour debt, splendid economic & demographic statistics. Login required; access instructions.
The Gambia | Guinea-Bissau | Mali | Senegal
•
167 items matching your criteria
Grant Proposal
Thibault Datry, Daniel Allen, Roger Argelich, Jose Barquin, Nuria Bonada, Andrew Boulton, Flora Branger, Yongjiu Cai, Miguel Cañedo-Argüelles, Núria Cid, Zoltán Csabai, Martin Dallimer, José Carlos de Araújo, Steven Declerck, Thijs Dekker, Petra Döll, Andrea Encalada, Maxence Forcellini, Arnaud Foulquier, Jani Heino, Franck Jabot, Patrícia Keszler, Leena Kopperoinen, Sven Kralisch, Annika Künne, Nicolas Lamouroux, Claire Lauvernet, Virpi Lehtoranta, Barbora Loskotová, Rafael Marcé, Julia Martin Ortega, Christine Matauschek, Marko Miliša, Szilárd Mogyorósi, Nabor Moya, Hannes Müller Schmied, Antoni Munné, François Munoz, Heikki Mykrä, Irina Pal, Riikka Paloniemi, Petr Pařil, Polona Pengal, Bálint Pernecker, Marek Polášek, Carla Rezende, Sergi Sabater, Romain Sarremejane, Guido Schmidt, Lisette Senerpont Domis, Gabriel Singer, Esteban Suárez, Matthew Talluto, Sven Teurlincx, Tim Trautmann, Amélie Truchy, Emmanouil Tyllianakis, Sari Väisänen, Liisa Varumo, Jean-Philippe Vidal, Annika Vilmi, Dolors Vinyoles
•
Abstract
An international ban on psychedelics initiated by the United Nations’ Convention on Psychotropic Substances in 1971 restricted the clinical use of these ancient psychoactive substances. Yet, in an era marked by rising mental health concerns and a growing “Deaths of Despair” epidemic (i.e., excess mortality and morbidity from suicide, drug overdose, and alcoholism), the structured psychedelic use that has long been a part of ritual healing experiences for human societies is slowly regaining credibility in Western medicine for its potential to treat various mental health conditions. We use a historical lens to examine the use of psychedelic therapies over time, translate ancient lessons to contemporary clinical and research practice, and interrogate the practical and ethical questions researchers must grapple with before they can enter mainstream medicine. Given the COVID-19 pandemic and its contributions to the global mental health burden, we also reflect on how psychedelic therapy might serve as a tool for medicine in the aftermath of collective trauma. Ultimately, it is argued that a “psychedelic renaissance” anchored in the lessons of antiquity can potentially help shift healthcare systems—and perhaps the broader society—towards practices that are more humane, atte